Tus-Pharmaceutical Group Co., Ltd.

Shenzhen Stock Exchange 000590.SZ

Tus-Pharmaceutical Group Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -4.44 M

Tus-Pharmaceutical Group Co., Ltd. Net Cash Used Provided By Financing Activities is USD -4.44 M for the year ending December 31, 2023, a -127.47% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Tus-Pharmaceutical Group Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 16.16 M, a 1,868.13% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -913.98 K, a -222.74% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 744.64 K, a 113.17% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -5.66 M, a -333.97% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Shenzhen Stock Exchange: 000590.SZ

Tus-Pharmaceutical Group Co., Ltd.

CEO	Ms. Ting Tang
IPO Date	Jan. 19, 1996
Location	China
Headquarters	No. 33, Yangliu Road
Employees	1,237
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Personal Care Tobacco

Description

Tus-Pharmaceutical Group Co., Ltd. manufactures and sells traditional Chinese medicine and western medicine products. The company was formerly known as Tus-Guhan Group Corp.,Ltd. Tus-Pharmaceutical Group Co., Ltd. was founded in 1956 and is based in Hengyang, China.

Key trends

Past 5 years